Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41
Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to...
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40
On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the...
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39
We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI)...
Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38
We jet off to Central London to meet Robin Carr, CEO of Myricx Bio, a...
Why ADCs and Radiopharmaceuticals Are Big Pharma’s New Obsession
Antibody-drug conjugates (ADCs) and radiopharmaceuticals have moved from the fringes of biotech buzzwords into the...
Baker Brothers’ Biotech Investing Secrets
In a biotech landscape dominated by hype and volatility, the Baker Brothers have emerged as...
![Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored]](https://flot.bio/wp-content/uploads/2025/07/Website-Thumbnail-Aino-Kalervo-1080x648.avif)
Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored]
We dive into the world of cutting-edge cancer treatments with Aino Kalervo, Chief Operating Officer...
Renee Aguiar-Lucander, Hansa Biopharma 🇸🇪 | Immunology, Gene therapy | E36
Fresh after leading Calliditas Therapeutics through a $1.1B acquisition, Renee Aguiar-Lucander takes us through her...
Stephane Bancel, Moderna | mRNA Therapeutics, Boston Biotech Mafia, AI Biotech | E35
We’re with Stephane Bancel, CEO of the US mRNA giant Moderna. The company’s 15-year trajectory has...
Chris Martin, Verona Pharma 🇬🇧 | Ohtuvayre, COPD, Execution | E34
We’re online with Chris Martin, COO of the 6th most valuable biotech in Europe, Verona Pharma. Their...
